|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08225 C HEALTH GP
Nominal 
0.160 -0.018 (-10.112%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 18,293 | 21.750% | 21,425 | 13,090 | 83,601 | 83,063 |
| Cost of Sales | -- | -- | (13,213) | (7,347) | (19,744) | -- |
| Gross Profit | -- | -- | 8,212 | 5,743 | 63,857 | -- |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (381) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | 18 | 15,585 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 8,651 | 26.218% | (58,211) | (15,826) | 42,521 | 70,796 | |
| Taxation | (1,298) | 26.265% | 0 | 0 | (6,196) | (10,146) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 197 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 7,353 | 26.210% | (58,014) | (15,826) | 36,325 | 60,650 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 15 | -- | (116) | (185) | (415) | 137 |
| Depreciation & Amortisation | -- | -- | 234 | 151 | 201 | 291 |
| Directors' Emoluments | -- | -- | 755 | 1,156 | 260 | 156 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Qualified | Qualified | Qualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 0.740 | 23.333% | -5.830 | -1.590 | 3.650 | 6.100 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.001 | (0.005) | (0.010) | 0.019 |
| NBV per share ($) | 0.093 | -- | 0.085 | 0.143 | 0.156 | 0.119 |
| Remarks: | Real time quote last updated: 25/11/2024 11:40 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 7,353,000 |
| %Change | 26.210% |
| EPS / (LPS) | RMB 0.007 |
| NBV Per Share (¥) | RMB 0.093 |